Open access
94
Views
19
CrossRef citations to date
0
Altmetric
Original Research
Hospital readmissions following initiation of nebulized arformoterol tartrate or nebulized short-acting beta-agonists among inpatients treated for COPD
Vamsi Bollu1 Sunovion Pharmaceuticals, Inc., Marlborough, MACorrespondence[email protected]
, Frank R Ernst2 Premier healthcare alliance, Charlotte, NC
, John Karafilidis1 Sunovion Pharmaceuticals, Inc., Marlborough, MA
, Krithika Rajagopalan1 Sunovion Pharmaceuticals, Inc., Marlborough, MA
, Scott B Robinson2 Premier healthcare alliance, Charlotte, NC
& Sidney S Braman3 The Icahn School of Medicine at Mount Sinai, New York, NY, USA
Pages 631-639
|
Published online: 06 Dec 2013
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.